Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling

British Journal of Clinical Pharmacology
Zheng Liu, Jennifer H Martin

Abstract

Model-based prediction on clinical doses for cannabinoids therapy is beneficial in the clinical setting, especially for seriously ill patients with both altered pharmacokinetics and pharmacodynamic responses. The objective of this article is to review the currently available PK and/or PD models of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to highlight the major issues for modelling this complex therapeutic area. A systematic search was conducted in the electronic databases PubMed and EMBASE using the key words 'cannabis', 'cannabinoid', 'tetrahydrocannabinol', 'THC', 'cannabidiol', 'CBD', 'pharmacokinetic model', 'pharmacodynamics model' and their combinations. Twelve empirical PK and/or PD models for THC for humans were identified. Among them, ten were developed from data of healthy participants and two were from ill patients. Models for CBD were not found. Model-based prediction on appropriate doses for cannabinoids therapy for ill patients is currently limited due to insufficiency of relevant PK and PD data. High-quality PK and PD data of cannabinoids for patients with different illnesses is needed for model development. Mechanism-based PK and PD models are promising for improved predictive dosing performance f...Continue Reading

References

Apr 1, 1990·Infusionstherapie : offizielles Organ der Deutschen Arbeitsgemeinschaft für Künstliche Ernährung (DAKE) ; offizielles Organ der Österreichischen Arbeitsgemeinschaft für Klinische Ernähru (AKE) ; offizielles Organ der Deutschen Gesellschaft für Transfusion·K C Fearon, T Preston
Feb 1, 1986·Biomedical & Environmental Mass Spectrometry·A OhlssonL E Hollister
Aug 1, 1984·Clinical Pharmacology and Therapeutics·C W Chiang, G Barnett
May 1, 1982·Clinical Pharmacology and Therapeutics·M Perez-ReyesC E Cook
Oct 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·G BarnettS M Owens
Sep 1, 1983·Clinical Pharmacology and Therapeutics·M E WallM Perez-Reyes
Mar 1, 1996·Age and Ageing·D KingM Lye
Oct 26, 1999·Journal of Gastroenterology and Hepatology·M TraunerR E Stauber
Nov 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·C Pichard, U G Kyle
Feb 21, 2002·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·H Kalant
Feb 18, 2006·Nature Reviews. Drug Discovery·Donald A Berry
Jan 26, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Edward T MorganChristopher J Sinal
May 11, 2010·Toxicology and Applied Pharmacology·Claudine C HunaultJan Meulenbelt
May 19, 2012·Journal of Psychopharmacology·Daniël KleinloogJoop van Gerven
Jun 12, 2012·British Journal of Clinical Pharmacology·Linda E KlumpersJoop M A van Gerven
Jan 1, 2012·CPT: Pharmacometrics & Systems Pharmacology·D R Mould, R N Upton
Jul 10, 2013·Drug Testing and Analysis·Wayne Hall, Louisa Degenhardt
Jun 5, 2014·The New England Journal of Medicine·Nora D VolkowSusan R B Weiss
Jul 3, 2015·Journal of Cachexia, Sarcopenia and Muscle·Katja Cvan TrobecMitja Lainscak
Feb 18, 2016·Clinical Pharmacokinetics·Stephanie E Reuter, Jennifer H Martin
Mar 18, 2016·JAMA Oncology·Gianna WilkieTina Rizack
Jun 11, 2016·Pharmacotherapy·Pius S FasinuLarry A Walker
Feb 9, 2017·Journal of Pharmacological and Toxicological Methods·A MarsotO Blin
Feb 27, 2017·Biochimica Et Biophysica Acta. Bioenergetics·Inge BosEmilie Wientjes
Sep 2, 2017·Cannabis and Cannabinoid Research·Kerstin Iffland, Franjo Grotenhermen
Oct 22, 2017·British Journal of Pharmacology·Stephen Ph AlexanderUNKNOWN CGTP Collaborators

❮ Previous
Next ❯

Citations

Aug 24, 2018·British Journal of Clinical Pharmacology·Jennifer H Martin, Noel Cranswick
Apr 14, 2019·British Journal of Clinical Pharmacology·Jennifer H Martin, Nicholas J Talley
Oct 29, 2019·British Journal of Clinical Pharmacology·Kirsten Riber BergmannGeert Jan Groeneveld
Feb 8, 2020·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Jyotpal Singh, John Patrick Neary
Apr 8, 2020·European Journal of Drug Metabolism and Pharmacokinetics·Janthima MethaneethornManupat Lohitnavy
Jan 20, 2019·Archives of Toxicology·J MaiaGeorgina Correia-da-Silva
Aug 18, 2020·Journal of Pain and Symptom Management·David CollisterMichael Walsh
Mar 27, 2021·Computers in Biology and Medicine·Jianan ZhaoN Sarah Arden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.